David Jenkins;Seth Alexander Ettenberg;Michael Patrick Morrissey;Vivien W. Chan
发明人:
Seth Alexander Ettenberg,Vivien W. Chan,Michael Patrick Morrissey,David Jenkins
申请号：
US14114418
公开号：
US20140056912A1
申请日:
2012.04.27
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The disclosure relates to methods for treating a sclerostin-expressing cancer, e.g., a squamous cell carcinoma (SCC), e.g., SCC of the upper aerodigestive tract, esophagus, or lung, employing a therapeutically effective amount of at least one sclerostin antagonist, e.g., an anti-sclerostin antibody, such as Antibody 1, 2, 3, 4 or 5.
